A Retrospective Review of Reclassification of Variants of Uncertain Significance in a Pediatric Epilepsy Cohort Undergoing Genetic Panel Testing

被引:0
|
作者
Chourasia, Nitish [1 ]
Vaidya, Rohan [1 ]
Sengupta, Soham [2 ]
Mefford, Heather C. [2 ]
Wheless, James [1 ]
机构
[1] Univ Tennessee, Le Bonheur Childrens Comprehens Epilepsy Ctr, Hlth Sci Ctr, Memphis, TN USA
[2] St Jude Childrens Res Hosp, Ctr Pediat Neurol Dis Res, Memphis, TN USA
关键词
Variants of uncertain significance; VUS; Genetic variant reclassification; Genetic epilepsy; Pediatric epilepsy; SYSTEMATIC REANALYSIS;
D O I
10.1016/j.pediatrneurol.2024.09.009
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The interpretation and communication of variant of uncertain significance (VUS) genetic results often present a challenge in clinical practice. VUSs can be reclassified over time into benign/likely benign (B/LB) or pathogenic/likely pathogenic (P/LP) based on the availability of updated data. We evaluate the frequency of VUS reclassification in our tertiary care epilepsy cohort undergoing epilepsy genetic panel (EGP) testing. Methods: Patients with established diagnoses of epilepsy (neonates to 18 years of age) who underwent EGP testing between 2017 and 2022 from a single commercial laboratory were evaluated. Patients who had any variant reclassified from their initial EGP report were included. Duration between reclassification of VUSs and types of reclassifications were compared between developmental and epileptic encephalopathy (DEE) versus non-DEE phenotypes. Results: Over the five years, 1025 probands were tested using EGP. Eighty-five probands (8%) had at least one genetic variant reclassified. A total of 252 initial VUSs were reported in the 85 probands, of which 113 (45%) VUSs were reclassified. Of 113 reclassification events, 21(19%) were upgraded to P/LP and 92 (81%) were reclassified to B/LB. The median (interquartile range) duration between variant reinterpretations in the cohort was 12 (14.5) months. There were no significant differences in the duration between reclassification and the likelihood of reclassification of VUSs to B/LB or P/LP between the two groups (DEE versus non-DEE). Conclusions: VUS reclassification over time can lead to clinically significant variant reinterpretation in patients with unknown genetic diagnoses. Periodic genomic test reinterpretation, preferably yearly, is recommended in routine clinical practice. (c) 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:101 / 107
页数:7
相关论文
共 50 条
  • [1] Variants of uncertain significance in prenatal microarrays: a retrospective cohort study
    Mardy, A. H.
    Wiita, A. P.
    Wayman, B., V
    Drexler, K.
    Sparks, T. N.
    Norton, M. E.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2021, 128 (02) : 431 - 438
  • [2] Rates of Variants of Uncertain Significance Among Patients With Breast Cancer Undergoing Genetic Testing: Regional Perspectives
    Abdel-Razeq, Hikmat
    Tamimi, Faris
    Abujamous, Lama
    Abdel-Razeq, Rashid
    Abunasser, Mahmoud
    Edaily, Sara
    Abdulelah, Hazem
    Khashabeh, Razan Abu
    Bater, Rayan
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [3] Prevalence of Variants of Uncertain Significance in Patients Undergoing Genetic Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome
    Chrysafi, Pavlina
    Jani, Chinmay T.
    Lotz, Margaret
    Al Omari, Omar
    Singh, Harpreet
    Stafford, Katherine
    Agarwal, Lipisha
    Rupal, Arashdeep
    Dar, Abdul Qadir
    Dangelo, Abby
    Lam, Prudence
    CANCERS, 2023, 15 (24)
  • [4] The Challenge of Genetic Variants of Uncertain Clinical Significance A Narrative Review
    Burke, Wylie
    Parens, Erik
    Chung, Wendy K.
    Berger, Sara M.
    Appelbaum, Paul S.
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (07) : 994 - +
  • [5] Rates and Classification of Variants of Uncertain Significance in Hereditary Disease Genetic Testing
    Chen, Elaine
    Facio, Flavia M.
    Aradhya, Kerry W.
    Rojahn, Susan
    Hatchell, Kathryn E.
    Aguilar, Sienna
    Ouyang, Karen
    Saitta, Sulagna
    Hanson-Kwan, Andrea K.
    Capurro, Nicole Nakousi
    Takamine, Eriko
    Jamuar, Saumya Shekhar
    McKnight, Dianalee
    Johnson, Britt
    Aradhya, Swaroop
    JAMA NETWORK OPEN, 2023, 6 (10) : E2339571
  • [6] Study of genetic variants and their clinical significance in Mexican pediatric patients with epilepsy
    Feria-Romero, Iris A.
    Reyes-Cuayahuitl, Aracely
    Sosa-Maldonado, Justina
    Montes-Aparicio, Alexia V.
    Rayo-Mares, Dario
    Perez-Perez, Daniel
    Grijalva-Otero, Israel
    Orozco-Suarez, Sandra
    GENE, 2023, 877
  • [7] Prevalence of pathogenic mutations and variants of uncertain significance in patients undergoing hereditary cancer genetic testing in Cambridge, MA.
    Jani, Chinmay
    Rupal, Arashdeep
    Al Omari, Omar
    Agarwal, Lipisha
    Stafford, Katherine A.
    Singh, Harpreet
    Dar, Abdul Qadir
    Lotz, Margaret
    Dangelo, Abby
    Lam, Prudence B.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] Strategic validation of variants of uncertain significance in ECHS1 genetic testing
    Kishita, Yoshihito
    Sugiura, Ayumu
    Onuki, Takanori
    Ebihara, Tomohiro
    Matsuhashi, Tetsuro
    Shimura, Masaru
    Fushimi, Takuya
    Ichino, Noriko
    Nagatakidani, Yoshie
    Nishihata, Hitomi
    Nitta, Kazuhiro R.
    Yatsuka, Yukiko
    Imai-Okazaki, Atsuko
    Wu, Yibo
    Osaka, Hitoshi
    Ohtake, Akira
    Murayama, Kei
    Okazaki, Yasushi
    JOURNAL OF MEDICAL GENETICS, 2023, 60 (10) : 1006 - 1015
  • [9] Genetic counselors' practices and confidence regarding variant of uncertain significance results and reclassification from BRCA testing
    Scherr, C. L.
    Lindor, N. M.
    Malo, T. L.
    Couch, F. J.
    Vadaparampil, S. T.
    CLINICAL GENETICS, 2015, 88 (06) : 523 - 529
  • [10] Comparing the frequency of variants of uncertain significance (VUS) between ancestry groups in a paediatric epilepsy cohort
    Martin, Bree E.
    Sands, Tristan
    Bier, Louise
    Bergner, Amanda
    Boehme, Amelia K.
    Lippa, Natalie
    JOURNAL OF MEDICAL GENETICS, 2024, 61 (07) : 645 - 651